| 2024/07/16 17:11:35 | |
|---|---|
| Price | |
| 1.195 EUR | |
| Difference | -5.53% (-0.07) |
General attributes
| ISIN | BE0974340722 |
| Symbol | SEQUA |
| Exchange | Euronext Brussels |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 37 EUR |
| Benchmark | BEL 20 INDEX |
Market data
| Bid (Bid size) | 1.19 EUR (844) |
| Ask (Ask size) | 1.23 EUR (1,000) |
| Open | 1.26 EUR |
| High | 1.285 EUR |
| Low | 1.17 EUR |
| Close (prev. day) | 1.265 EUR |
| VWAP | 1.213391 EUR |
| Volume (pcs) | 44,494 |
| Trading volume | 53,989.00 |
| Number of trades | 88 |
| Last size | 300 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: SEQUANA MEDICAL NV |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/05/29 |
|
Global Equity Ratings |
|
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/07/16 17:11:35 | |
|---|---|
| Price | |
| 1.195 EUR | |
| Difference | -5.53% (-0.07) |
General attributes
| ISIN | BE0974340722 |
| Symbol | SEQUA |
| Exchange | Euronext Brussels |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 37 EUR |
| Benchmark | BEL 20 INDEX |
Market data
| Bid (Bid size) | 1.19 EUR (844) |
| Ask (Ask size) | 1.23 EUR (1,000) |
| Open | 1.26 EUR |
| High | 1.285 EUR |
| Low | 1.17 EUR |
| Close (prev. day) | 1.265 EUR |
| VWAP | 1.213391 EUR |
| Volume (pcs) | 44,494 |
| Trading volume | 53,989.00 |
| Number of trades | 88 |
| Last size | 300 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -65.86% | -61.45% | -83.45% |
| Perf (abs.) | -2.31 | -1.91 | -6.03 |
| Beta | -1.59 | -0.54 | 0.28 |
| Volatility | 89.34 | 87.99 | 66.23 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 1.277 EUR (16,344) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 1.408 EUR (19,823) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 1.648 EUR (73,387) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 2.601 EUR (44,222) |
| YTD High | date | 4.850 EUR (2024/01/08) |
| YTD Low | date | 1.170 EUR (2024/07/16) |
| 52 Weeks High | date | 4.850 EUR (2024/01/08) |
| 52 Weeks Low | date | 1.170 EUR (2024/07/16) |
All listings for SEQUANA MEDICAL NV
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Stuttgart | 2024/07/16 | 13:33 | 1.19 EUR | 0.00 | 4 |
| Munich | 2024/07/16 | 08:08 | 1.315 EUR | 0.00 | 2 |
| Frankfurt | 2024/07/16 | 08:02 | 1.215 EUR | 0.00 | 2 |
| FINRA other OTC Issues | 2024/02/21 | 16:48 | 3.00 USD | 0.01 | 2 |
| Euronext Brussels | 2024/07/16 | 17:11 | 1.195 EUR | 0.05 | 88 |
| Duesseldorf | 2024/07/16 | 08:12 | 1.23 EUR | 0.00 | 3 |
Company Logo
Contact Details
| SEQUANA MEDICAL NV |
| - - |
| Kortrijksesteenweg 1112, Sint-Denijs-Westrem - 9051 Ghent |
| Telefon: +32-9-298-28-28 |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: SEQUANA MEDICAL NV | |
Company Profile
Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company focuses on the treatment solutions for the management of liver disease, heart failure, malignant ascites, and other fluid imbalance disorders. It offers alfapump, an implantable, programmable, wirelessly-charged, battery-powered system that manages refractory ascites and malignant ascites. The company was founded by Noel L. Johnson in 2006 and is headquartered in Ghent, Belgium. |
Members of Management Board
| Ian Crosbie | Chairman of Managing Board |
| Andreas Wirth | Member of Executive Committee |
| Dragomir Lakic | Member of Executive Committee |
| Gijs Klarenbeek | Member of Executive Committee |
| Kirsten Van Bockstaele | Member of Executive Committee |
| Martijn Blom | Member of Executive Committee |
| Oliver Gödje | Member of Executive Committee |
| Timur Resch | Member of Executive Committee |
Board of directors
| Pierre Hubert Andre Chauvineau | Chairman of Supervisory Board |
| Ken MacLeod | Member of Supervisory Board |
| Rudy Dekeyser | Member of Supervisory Board |
| Alexandra Clyde | Member of Supervisory Board |
| Douglas Kohrs | Member of Supervisory Board |
| Ids van der Weij | Member of Supervisory Board |
| Jacqueline Fielding | Member of Supervisory Board |
| Wim Ottevaere | Member of Supervisory Board |